Assignee
MINGHUI PHARMACEUTICAL SHANGHAI LTD
CN·1 granted patent·2 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
3 records- 0143US2023099739A1Jak kinase inhibitor and preparation and application thereofMINGHUI PHARMACEUTICAL SHANGHAI LTD·Filed 2021·Application pending·0 cites
- 0240US12384786B2Cyclic molecules as Bruton's tyrosine kinase inhibitorMINGHUI PHARMACEUTICAL SHANGHAI LTD·Filed 2020·Granted Aug 12, 2025·0 cites·11 claims
- 0338US2023212294A1Anti-b7-h3 antibody and preparation therefor and use thereofMINGHUI PHARMACEUTICAL SHANGHAI LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MINGHUI PHARMACEUTICAL SHANGHAI LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →